Cardiovascular disease complicates% 1% to 3% of all pregnancies and is responsible for
10% to 15% of maternal mortality. Although its prevalence is considered relatively low in …

One-third of women with heart disease use medication for the treatment of cardiovascular
disease (CVD) during pregnancy. Increased plasma volume, renal clearance, and liver …

The continuation of warfarin throughout pregnancy in patients with a mechanical valve
prosthesis is a valid anticoagulation regimen, provided that warfarin dose does not exceed 5 …

The management of women with mechanical heart valves during pregnancy remains difficult
and controversial. There is no ideal anticoagulation regimen for this unique population, as …

Background A retrospective analysis of the records of all the patients of heart disease with
pregnancy at AIIMS, New Delhi, India, to find out the maternal and fetal outcome. Materials …

Objective To develop recommendations on the evaluation and management of patients with
rheumatic autoimmune and inflammatory diseases during the reproductive age, pregnancy …

Background Pregnancy in women with autoimmune rheumatic diseases is associated with
several maternal and foetal complications. The development of clinical practice guidelines …

Implantation of prosthetic valve requires consideration for anticoagulation. The current
guideline recommends warfarin on all mechanical valves. Dabigatran is the new generation …

Introduction Pregnancy is associated with a hypercoagulable state, which makes pregnant
women with prosthetic heart valves at high risk of thromboembolism. The proper …

Valvular heart diseases (VHD) are a major cause of cardiovascular morbidity and mortality
worldwide. As degenerative and functional mechanisms represent the main etiologies in …